Current
tests for severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) detect either the constituent nucleic acids/proteins
of the viral particles or antibodies specific to the virus, but cannot
provide information about viral neutralization by an antibody and
the efficacy of an antibody. Such information is important about individuals’
vulnerability to severe symptoms or their likelihood of showing no
symptoms. We immobilized online SARS-CoV-2 spike (S1) protein and
angiotensin-converting enzyme 2 (ACE2) into separate surface plasmon
resonance (SPR) channels of a tris-nitrilotriacetic acid (tris-NTA)
chip to simultaneously detect the anti-S1 antibody and viral particles
in serum samples. In addition, with a high-molecular-weight-cutoff
filter, we separated the neutralized viral particles from the free
antibody molecules and used a sensing channel immobilized with Protein
G to determine antibody-neutralized viral particles. The optimal density
of probe molecules in each fluidic channel can be precisely controlled
through the closure and opening of the specific ports. By utilizing
the high surface density of ACE2, multiple assays can be carried out
without regenerations. These three species can be determined with
a short analysis time (<12 min per assay) and excellent sensor-to-sensor/cycle-to-cycle
reproducibility (RSD < 5%). When coupled with an autosampler, continuous
assays can be performed in an unattended manner at a single chip for
up to 6 days. Such a sensor capable of assaying serum samples containing
the three species at different levels provides additional insights
into the disease status and immunity of persons being tested, which
should be helpful for containing the SARS-CoV-2 spread during the
era of incessant viral mutations.